No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Corporate Candidates to Announce Accelerate Share Buybacks: Trivariate
Express News | Haemonetics Completes Sale of Whole Blood Assets to Gvs, S.p.a
Press Release: Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025
Barrington Reaffirms Their Buy Rating on Haemonetics (HAE)
Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference